We are live on
!
Find out more
HCM
Horan Capital Management Portfolio holdings
AUM
$794M
1-Year Est. Return
30.86%
This Fund
S&P 500
This Quarter
Est. Return
+3.5%
1 Year Est. Return
+30.86%
3 Year Est. Return
+69.18%
5 Year Est. Return
+124.11%
10 Year Est. Return
–
AUM
$481M
AUM Growth
+$24M
(+5.3%)
Cap. Flow
+$8.86M
Cap. Flow
% of AUM
1.84%
Top 10 Holdings %
Top 10 Hldgs %
46.47%
Holding
81
New
13
Increased
13
Reduced
39
Closed
16
Avg Time Held
6.7
quarters
Top 10 Avg Time Held
6.8
quarters
Top 20 Avg Time Held
8.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$5.75M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$4.23M |
| 3 |
Nike
NKE
|
+$1.9M |
| 4 |
AGN
Allergan plc
AGN
|
+$1.1M |
| 5 |
Biogen
BIIB
|
+$891K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$28.9M |
| 2 |
Amazon
AMZN
|
+$23.6M |
| 3 |
Apple
AAPL
|
+$18.4M |
| 4 |
Bank of America
BAC
|
+$13.3M |
| 5 |
American Express
AXP
|
+$4.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.97% |
| 2 | Healthcare | 17.59% |
| 3 | Financials | 15.13% |
| 4 | Technology | 10% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$4.27T
| $26.1M | 5.42% |
543,820
+10,760
| +2% | +$501K |
2013 Q2
17 quarters
|
|
2
Visa
V
$744B
| $24.2M | 5.03% |
230,130
+341
| +0.1% | +$34.6K |
2013 Q2
17 quarters
|
|
3
Gilead Sciences
GILD
$183B
| $22.5M | 4.68% |
278,265
-1,469
| -0.5% | -$112K |
2016 Q1
6 quarters
|
|
4
Microsoft
MSFT
$4.04T
| $21.3M | 4.43% |
286,032
-3,383
| -1% | -$247K |
2013 Q2
17 quarters
|
|
5
Citigroup
C
$209B
| $19.9M | 4.13% |
273,493
-1,836
| -0.7% | -$125K |
2013 Q2
17 quarters
|
|
6
Wells Fargo
WFC
$244B
| $18M | 3.75% |
327,097
+16,695
| +5% | +$887K |
2013 Q2
17 quarters
|
|
7
Walmart Inc
WMT
$891B
| $17.7M | 3.67% |
678,735
-9,537
| -1% | -$250K |
2013 Q2
17 quarters
|
|
8
Procter & Gamble
PG
$355B
| $17M | 3.54% |
187,162
-2,941
| -2% | -$268K |
2013 Q2
17 quarters
|
|
9
Bristol-Myers Squibb
BMY
$116B
| $15.8M | 3.28% |
247,956
+5,075
| +2% | +$296K |
2017 Q1
2 quarters
|
|
10
Emerson Electric
EMR
$91.2B
| $14.3M | 2.97% |
227,286
-2,839
| -1% | -$171K |
2015 Q3
8 quarters
|
|
11
GE Aerospace
GE
$319B
| $12.4M | 2.57% |
106,731
-2,795
| -3% | -$338K |
2013 Q2
17 quarters
|
|
12
Union Pacific
UNP
$168B
| $12.2M | 2.53% |
104,987
-291
| -0.3% | -$31.2K |
2015 Q1
10 quarters
|
|
13
US Bancorp
USB
$88.6B
| $10.7M | 2.22% |
198,995
-6,741
| -3% | -$353K |
2013 Q2
17 quarters
|
|
14
Cisco
CSCO
$454B
| $10.6M | 2.2% |
314,548
-3,720
| -1% | -$118K |
2013 Q2
17 quarters
|
|
15
iShares Core US Aggregate Bond ETF
AGG
$137B
| $9.93M | 2.06% |
90,583
-106
| -0.1% | -$11.6K |
2015 Q3
8 quarters
|
|
16
Pfizer
PFE
$162B
| $9.85M | 2.05% |
290,802
-3,803
| -1% | -$122K |
2013 Q2
17 quarters
|
|
17
Polaris
PII
$2.94B
| $9.72M | 2.02% |
92,926
-1,306
| -1% | -$124K |
2016 Q1
6 quarters
|
|
18
CVS Health
CVS
$112B
| $9.52M | 1.98% |
117,113
+11,137
| +11% | +$881K |
2015 Q1
10 quarters
|
|
|
AGN
19
DELISTED
Allergan plc
AGN
| $8.89M | 1.85% |
43,375
+4,748
| +12% | +$1.1M |
2016 Q4
3 quarters
|
|
20
Oracle
ORCL
$434B
| $8.56M | 1.78% |
177,097
-3,656
| -2% | -$182K |
2013 Q2
17 quarters
|
|
21
Johnson & Johnson
JNJ
$599B
| $8.07M | 1.68% |
62,063
-755
| -1% | -$100K |
2013 Q2
17 quarters
|
|
22
Qualcomm
QCOM
$189B
| $7.7M | 1.6% |
148,475
-1,879
| -1% | -$99.4K |
2014 Q4
11 quarters
|
|
|
23
Biogen
BIIB
$33.8B
| $7.35M | 1.53% |
23,477
+3,009
| +15% | +$891K |
2016 Q2
5 quarters
|
|
|
MON
24
DELISTED
Monsanto Co
MON
| $7.2M | 1.5% |
60,088
-2,087
| -3% | -$246K |
2016 Q1
6 quarters
|
|
25
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$553M
| $6.9M | 1.43% |
132,122
-500
| -0.4% | -$26.1K |
2016 Q1
6 quarters
|
|
Similar funds
DBC
BII
HCMNY
DK
AVAX
IVA
LCM
WEC
Horan Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Horan Capital Management held 81 positions worth $481M, up 5.3% from $457M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Horan Capital Management's Q3 2017 filing shows 13 new, 13 increased, 39 reduced and 16 closed positions. Its largest new stake was TJX Companies: 161,470 shares worth $5.95M. The largest sale was Berkshire Hathaway Class B, an estimated $28.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 6.4% a quarter earlier, followed by Healthcare and Financials.
- Horan Capital Management's largest Q3 2017 buy was TJX Companies: 161,470 shares worth $5.95M.
- Horan Capital Management added most to Nike in Q3 2017, an estimated $1.9M increase.
- Horan Capital Management's biggest Q3 2017 reduction was Yum! Brands, cutting an estimated $1.38M.
- Horan Capital Management fully exited Berkshire Hathaway Class B in Q3 2017, selling an estimated $28.9M.
- Horan Capital Management's ten largest holdings make up 46% of its $481M portfolio in Q3 2017.
- Horan Capital Management opened 13 new positions and closed 16 in Q3 2017.
- Horan Capital Management's portfolio value rose 5.3% quarter-over-quarter to $481M.
Based on Horan Capital Management's 13F filing for Q3 2017, filed 10 Oct 2017.